What's New at the RI-MUHC ?

How a few drops of blood led to a breakthrough in immunology

Scientists from the Research Institute of the McGill University Health Centre (RI-MUHC) may have cracked the code to understanding...

Biofilms—the eradication has begun

Have you ever heard of biofilms? They are slimy, glue-like membranes that are produced by microbes, like bacteria and fungi, in order to...

The MUHC Foundation launches a $10-million fundraising campaign for research

More than 150 guests joined the McGill University Health Centre (MUHC) Foundation to celebrate the achievements of two Montreal...

Kidney graft success - does age and sex matter?

The success of kidney transplant is dependent on the age and sex of both the donor and the recipient, according to research published...

On the genetics trail

Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical...

Encouraging results for patients with aggressive brain cancer

Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types...

A prescription with legs!

A study from the Research Institute of the McGill University Health Centre (RI-MUHC) shows that physician-delivered step count...

What is high Lipoprotein(a), and should I be concerned?

A team of researchers from the Research Institute of the McGill University Health Center (RI-MUHC) found that elevations in a unusual...

New marker and potential therapy for triple negative breast cancer

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...

A surprise advance in the treatment of adult cancers

A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of...

New marker identified for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...

A race against time to diagnose deadly weight loss in cancer patients

About one third of cancer patients die because of cachexia – an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely...

A key to unlocking the mystery of triple negative breast cancer

A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor...

RI-MUHC researchers discover new path to stop the spread of cancer

Investigators from the Research Institute of the McGill University Health Centre (RI-MUHC), and the Institute of Cancer Research, London (UK), have discovered...

Brain’s biological clock stimulates thirst before sleep

The brain’s biological clock stimulates thirst in the hours before sleep, according to a study published in the journal...

Pets and Children are a Potential Source of C. difficile in the Community

New research at the RI-MUHC shows high rate of household transmission of bacteria

Inappropriate and overuse of antibiotics in fight against tuberculosis in India

Simulated patient study sheds new light on antibiotic use in India

Critical years ahead in fight against hepatitis C virus

In the last five years, new drugs have revolutionized the treatment of hepatitis C (HCV), a virus that causes serious liver disease.

Researchers discover new genetic mutation linked to osteonecrosis of the hip

Scientists at the Research Institute of McGill University Health Centre (RI-MUHC) have discovered a new genetic mutation linked to osteonecrosis of the hip...

Daily dose of caffeine impairs recovery after noise-induced hearing loss

A new study by investigators at the Research Institute of the McGill University Health Centre (RI-MUHC) has discovered that daily consumption of caffeine can impair recovery...